Ahmad Almawi, PhD, has joined the team at the CMI as a protein scientist. Ahmad trained as a structural biologist and has expertise in protein production and purification. He will be spearheading the nanobody production effort.
In response to the COVID-19 pandemic, the CMI is closing for general access. See the latest guidelines from Harvard Medical School (https://hms.harvard.edu/coronavirus) for more information. If you are doing COVID-19 research and require access to CMI instrumentation, contact Kelly Arnett at cmi@hms.harvard.edu.
Thanks to generous funding from the HMS Foundry, the CMI will be adding new instrumentation and new services in the coming months. Stay tuned for more information.
